SEC Form 4 · accession 0001645627-17-000101
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 27, 2017
Accepted (ET)
Jul 31, 2017 · 3:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2017 | P | 3,000 | $0.0423 | A | 22,034,389 | D | |
| Common Stock | Jul 27, 2017 | P | 3,000 | $0.04 | A | 22,037,389 | D | |
| Common Stock | Jul 27, 2017 | P | 3,000 | $0.04 | A | 22,040,389 | D | |
| Common Stock | Jul 27, 2017 | P | 4,000 | $0.04 | A | 22,044,389 | D | |
| Common Stock | Jul 27, 2017 | P | 1,000 | $0.04 | A | 22,045,389 | D | |
| Common Stock | Jul 27, 2017 | P | 2,000 | $0.04 | A | 22,047,389 | D | |
| Common Stock | Jul 27, 2017 | P | 3,000 | $0.037 | A | 22,050,389 | D | |
| Common Stock | Jul 27, 2017 | P | 2,000 | $0.0369 | A | 22,052,389 | D | |
| Common Stock | Jul 27, 2017 | P | 1,500 | $0.0368 | A | 22,053,889 | D | |
| Common Stock | Jul 27, 2017 | P | 5,000 | $0.0369 | A | 22,058,889 | D | |
| Common Stock | Jul 28, 2017 | P | 3,000 | $0.0369 | A | 22,061,889 | D | |
| Common Stock | Jul 28, 2017 | P | 2,000 | $0.0419 | A | 22,063,889 | D | |
| Common Stock | Jul 28, 2017 | P | 3,000 | $0.0399 | A | 22,066,889 | D | |
| Common Stock | Jul 28, 2017 | P | 5,000 | $0.0399 | A | 22,071,889 | D | |
| Common Stock | Jul 28, 2017 | P | 2,000 | $0.04 | A | 22,073,889 | D | |
| Common Stock | Jul 28, 2017 | P | 2,000 | $0.0399 | A | 22,075,889 | D |
Table II — derivative securities
No Table II lines on this filing.